Anderson Rodrigues de Almeida
Overview
Explore the profile of Anderson Rodrigues de Almeida including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
128
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Constantino Cunha E, de Almeida A, Dantas A, de Oliveira Goncalves M, Pereira M, Guimaraes Goncalves R, et al.
Clin Chim Acta
. 2025 Feb;
569:120177.
PMID: 39894192
Background: Systemic sclerosis (SSc) is a complex disease whose diagnosis is based on clinical manifestations, serological testing for autoantibodies, and nailfold capillaroscopy. Although some proteins have been proposed as biomarkers,...
2.
de Almeida A, Mendonca Junior F, Dantas A, de Oliveira Goncalves M, Chene C, Jeljeli M, et al.
Int Immunopharmacol
. 2024 Jun;
136:112344.
PMID: 38833846
Systemic sclerosis (SSc) is a devastating autoimmune illness with a wide range of clinical symptoms, including vascular abnormalities, inflammation, and persistent and progressive fibrosis. The disease's complicated pathophysiology makes it...
3.
Machado L, Dezordi F, de Lima G, Lima R, Silva L, Pereira L, et al.
Microbiol Spectr
. 2024 Apr;
12(6):e0421823.
PMID: 38651879
SARS-CoV-2 virus emerged as a new threat to humans and spread around the world, leaving a large death toll. As of January 2023, Brazil is among the countries with the...
4.
de Almeida A, Dantas A, de Oliveira Goncalves M, Chene C, Jeljeli M, Chouzenoux S, et al.
Inflammopharmacology
. 2023 Jul;
32(1):433-446.
PMID: 37477795
Thiazolidinediones (TZD) are synthetic molecules that have a range of biological effects, including antifibrotic and anti-inflammatory, and they may represent a promising therapeutic strategy for systemic sclerosis (SSc). The aim...
5.
Ranzolin A, Lopes Marques C, da Rocha Junior L, Duarte A, de Lima H, de Almeida Martins L, et al.
Adv Rheumatol
. 2022 Nov;
62(1):44.
PMID: 36376923
Background/objective: The effects of Chikungunya virus (CHIKV) infection on patients with rheumatic diseases have not been extensively studied. Our aim was to compare the clinical course of patients with rheumatoid...
6.
Oliveira P, de Oliveira Silva B, Pessoa E Silva R, Galdino L, Carvalho V, de Almeida A, et al.
J Virol Methods
. 2022 Apr;
305:114529.
PMID: 35398116
The maintenance of SARS-Cov-2 RNA samples poses a new challenge for laboratories and researchers. In addition, it is a requirement in order to identify what strain of the new coronavirus...
7.
Dantas A, Souza R, de Almeida A, Xavier Junior F, Pitta M, Barreto de Melo Rego M, et al.
Molecules
. 2021 Jul;
26(13).
PMID: 34202367
Carvacrol (CV) is an essential oil with numerous therapeutic properties, including immunomodulatory activity. However, this effect has not been studied in nanoemulsion systems. The objective of this study was to...
8.
Constantino Cunha E, Albertina Dantas de Lima C, de Melo Vilar K, Nobrega M, de Almeida A, Pereira M, et al.
Autoimmunity
. 2021 May;
54(4):187-194.
PMID: 33973825
Introduction: Systemic sclerosis (SSc) is a rare complex disease characterized by vascular damage, autoimmunity, and extensive skin and internal organs fibrosis. Galectin-3 (Gal-3) is encoded by gene (Lectin, Galactoside-Binding, Soluble,...
9.
de Almeida A, Dantas A, Pereira M, Barreto de Melo Rego M, Guimaraes Goncalves R, da Rocha Pitta I, et al.
Immunobiology
. 2020 Jun;
225(3):151964.
PMID: 32517886
Objective: The objective of the present study was to evaluate the serum levels of soluble oncostatin M (OSM), OSM receptor (sOSMR) and glycoprotein130 (sgp130) in patients with systemic sclerosis (SSc),...
10.
da Rocha Junior L, Duarte A, Barreto de Melo Rego M, de Almeida A, de Melo Vilar K, de Lima H, et al.
Immunol Lett
. 2020 Jan;
220:38-43.
PMID: 31954799
Background: Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by chronic and progressive inflammation that can cause a high degree of disability in affected individuals. Proinflammatory cytokines play central...